Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine the analgesic efficacy and safety of Meloxicam Injection in subjects undergoing abdominal surgery.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05950152
Study type Interventional
Source Beijing Tide Pharmaceutical Co., Ltd
Contact yangwen ou, medical doctor
Phone 0731-88618151
Email ouyangwen139@126.com
Status Not yet recruiting
Phase Phase 2
Start date July 2023
Completion date February 2024

See also
  Status Clinical Trial Phase
Completed NCT02284243 - Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy Surgery Phase 2
Completed NCT02720692 - Evaluation of N1539 Following Major Surgery Phase 3
Completed NCT03456141 - Multimodal Analgesic Protocol to Moderate Acute Pain
Terminated NCT02169336 - Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy Phase 2
Completed NCT02678286 - Evaluation of N1539 Following Abdominoplasty Surgery Phase 3
Completed NCT02675907 - Evaluation of N1539 Following Bunionectomy Surgery Phase 3
Unknown status NCT01041313 - Memantine for Post-Operative Pain Control Phase 4
Completed NCT02540265 - Placebo-Controlled Evaluation of N1539 Following Bunionectomy Surgery Phase 2
Completed NCT03154658 - Serratus Anterior Plane Block in Patients Undergoing Mastectomy Phase 4